DMRA Damora Therapeutics, Inc.
P/E
--
Forward P/E
--
Price/Sales
--
Beta
1.435
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🔴 Damora Therapeutics, Inc. is trading 5.4% down today, extending a multi-day slide amid biotech volatility
Damora Therapeutics, Inc. is trading 5.4% down at $21.12 today, extending a multi-day slide from recent closes above $24 amid broader volatility in the...
🔴 Damora Therapeutics, Inc. is trading 5.1% down today with no clear catalyst
Damora Therapeutics, Inc. is trading 5.1% down at $23.59 today, as the stock experiences an idiosyncratic move with no clear company-specific catalyst to...
Damora Therapeutics Lands $66 Million Stake Following 700% Stock Surge
FCPM III Services B.V. disclosed a new $65.6 million stake in Damora Therapeutics. The investment fund acquired 2,441,000 shares as of March 31, 2026. This...